Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment. Lunit AI can empower you to enhance diagnostic performance. Our AI for chest x-ray and 2D & 3D mammography has been validated through 100+ publications in peer-reviewed journals such as JAMA Oncology, Lancet Digital Health and Radiology, and is now in use in 3,500+ sites globally. < Lunit AI Suite for Radiology > • Lunit INSIGHT CXR, AI Solution for Chest X-ray • Lunit INSIGHT MMG, AI Solution for Mammography • Lunit INSIGHT DBT, AI Solution for Digital Breast Tomosynthesis • Lunit CXR Triage, AI solution for Chest X-ray Triage *emergency department use, available in the US only *If you are interested in Lunit Oncology, please visit Lunit Oncology’s LinkedIn page.
我們正在追蹤 Lunit Cancer Screening 的市場擴張
過去 90 日內有 21 個訊號。
Lunit Cancer Screening 的國際擴張與競爭對手的比較
Lunit Cancer Screening你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Lunit Cancer Screening你 | 0 | 0 | — | 0 | 0 |
(Seoul) Senior AX Engineer
查看招聘Seoul, Seoul, South Korea · Full-time · 3日前
(Global) Technical Service Engineer · Japan
查看招聘Tokyo, Tokyo, Japan · 4日前
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
查看招聘North Carolina, United States · 4日前
AI-powered chest X-ray analysis for faster, more accurate diagnoses
進行中
L’IA au service des radiologues pour un dépistage du cancer du sein fiable
已結束
RSNA 2025: Measuring the Clinical Impact of AI in 3D Breast Imaging
已結束Lunit因衍生金融負債評估收益面臨股價困境。公司計劃通過2500億韓元供股解決可轉債提前贖回問題，但會計問題仍未解決。
Lunit在2026年歐洲放射學大會上發表21項研究成果，展示乳房X光攝影、胸部X光分析和乳房密度量化的AI解決方案。
Lunit將在AACR 2026展示六項AI生物標誌物平台研究，展示癌症研究和治療預測的進展。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Lunit Cancer Screening 業務、市場及增長訊號的快速解答。
